Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused

NCT05247476 is registered in ClinicalTrials.gov with Zhongshan Hospital Xiamen University as lead sponsor.

NCT NCT05247476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05247476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused
Lead sponsor
Zhongshan Hospital Xiamen University
Phase
Phase 4
Overall status
Unknown status
Start date
October 18, 2021
Completion date
September 30, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypothyroidism, thyroid cancer, papillary